A non-random deletion in the p53 gene in oral squamous cell carcinoma

British Journal of Cancer

Volumn 73, Issue 11, 1996, Pages 1381-1386

  Nylander, K ^a   Schildt, E B ^a   Eriksson, M ^a   Magnusson, A ^b   Mehle, C ^a   Roos, G ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

Author keywords

Deletion; Epidemiology; Head and neck; p53 gene; Squamous cell carcinoma

Indexed keywords

PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; EXON; GENE DELETION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MOUTH CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA; STOP CODON;

EID: 0029886709     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.262     Document Type: Article

References (36)

1. AHOMADEGBE JC, BARROIS M, FOGEL S, LE BIHAN ML, DOUCRACY S, DUVILLARD P, ARMAND JP AND RIOU G. (1995). High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumours and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early noninvasive lesions. Oncogene, 10, 1217-1227.
2. BOYLE JO, HAKIM J, KOCH W, VAN DER RJET P, HRUBAN RH, ROA RA, CORREO R, EBY YJ, RUPPERT JM AND SIDRANSKY D. (1993). The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res., 53, 4477-4480.
3. BRACHMAN DG, GRAVES D, VOKES E, BECKETT M, HARAF D, MONTAG A, DUNPHY E, MICK R, YANDELL D AND WEICHSELBAUM RR. (1992). Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res., 52, 4832-4836.
4. BRENNAN JA, BOYLE JO, KOCH WM, GOODMAN SN, HRUBAN RH, EBY YJ, COUCH MJ, FORASTIERE AA AND SIDRANSKY D. (1995). Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 332, 712-717.
5. BURNS JE, BAIRD MC, CLARK LJ, BURNS PA, EDINGTON K, CHAPMAN C, MITCHELL R, ROBERTSON G, SOUTAR D AND PARKINSON EK. (1993). Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br. J. Cancer, 67, 1274-1284.
6. CARRIER F, SMITH ML, BAE I, KILPATRICK KE, LANSING TJ, CHEN CY, ENGELSTEIN M, FRIEND SH, HENNER WD, GILMER TM, KASTAN MB AND FORNACE Jr AJ.(1994). Characterization of human Gadd45, a p53-regulated protein. J. Biol. Chem., 269, 32672-32677.
7. CROOK T, MARSTON NJ, SARA EA AND VOUSDEN KH. (1994). Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell, 79, 817-827.
8. EL-DEIRY WS, TOKINO T, VELCULESCU VK, LEVY DB, PARSONS R, TRENT JM, LIN D, MERCER WE, KINZLER KW AND VOGELSTEIN B. (1993). WAF1, a potential mediator of p53 tumour suppression. Cell, 75, 817-825.
9. FIELD JK, PAVELIC ZP, SPANDIDOS DA, STAMBROOK PJ, JONES AS AND GLUCKMAN JL. (1993). The role of the p53 tumour suppressor gene in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head and Neck Surg., 119, 1118-1122.
10. GAIDANO G, BALLERINI P, GONG JZ, INGHIRAMI G, NERI A, NERI A, NEWCOMB EW, MAGRATH IT, KNOWLES DM AND DALLAFAVERA R. (1991). p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukaemia. Proc. Natl Acad. Sci. USA, 88, 5413-5417.
11. GREENBLATT MS, BENNETT WP, HOLLSTEIN M AND HARRIS CC. (1994). Mutations in the p53 tumour suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
12. HARPER JW, ADAMI GR, WEI N, KEYOMARSI K AND ELLEDGE SJ. (1993). The p21 cdk interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
13. HUANG Y, MELTZER SJ, YIN J, TONG Y, CHANG EH, SRIVASTAVA S, MCDANIEL T, BOYNTON Rf AND ZOU ZQ. (1993). Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Cancer Res., 53, 1889-1894.
14. HUANG Y, YIN J AND MELTZER SJ. (1994). A unique p53 intragenic deletion flanked by short direct repeats results in loss of mRNA expression in a human esophageal carcinoma. Carcinogenesis, 15, 1653-1655.
15. JEFFREY PD, GORINA S AND PAVLEVITCH NP. (1995). Crystal structure of the tetramerization domain of the p53 tumour suppressor at 1.7 Angstroms. Science, 267, 1498-1502.
16. JEGO N, THOMAS G AND HAMELIN R. (1993). Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers. Oncogene, 8, 209-213.
17. KARLSEN F, KALANTARI M, CHITEMERERE M, JOHANSSON B AND HAGMAR B. (1994). Modifications of human and viral deoxyribonucleic acid by formaldehyde fixation. Lab. Invest., 71, 604-611.
18. LANE DP. (1992). p53, guardian of the genome. Nature, 358, 15-16.
19. LEVINE AJ, PERRY ME, CHANG A, SILVER A, DITTMER D, WU M AND WELSH D. (1994). The 1993 Walter Hubert Lecture: The role of the p53 tumour suppressor gene in tumorigenesis. Br. J. Cancer, 69, 409-416.
20. MAGNUSSON KP, BERKE Z, MUNCK-WIKLAND E, LEWENSONFUCHS I, KLEIN G, DALLIANIS T AND WIMAN KG. (1995). In frame deletion of intron 7 in the p53 gene in a human tonsil tumour. Int. J. Oncol., 6, 27-29.
21. MOMAND J, ZAMBETTI GP, OLSON DC, GEORGE D AND LEVINE AJ. (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245.
22. MOYRET C, THEILLET C, LAURENT PUIG P, MÓLES JP, THOMAS G AND HAMELIN R. (1994). Relative efficiency of denaturing gradient gel electrophoresis and single strand conformation polymorphism in the detection of mutations in exons 5 to 8 of the p53 gene. Oncogene, 9, 1739-1743.
23. NYLANDER K, NILSSON P, MEHLE C AND ROOS G. (1995). p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck. Br. J. Cancer, 71, 826-830.
24. PUISIEUX A, LIM A, GROOPMAN J AND OZTURK M. (1991). Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res., 51, 6185-6189.
25. SAKAI E AND TSUCHIDA N. (1992). Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumour-suppressor genes. Oncogene, 7, 927-933.
26. SHAULIAN E, HAVIV I, SHAUL Y AND OREN M. (1995). Transcriptional repression by the C-terminal domain of p53. Oncogene, 10, 671-680.
27. SHAULSKY G, GOLDFINGER N, BEN-ZÉEV A AND ROTTER V. (1990). Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumourigenesis. Mol. Cell. Biol., 10, 6565-6577.
28. SHIBATA K. (1992). The polymerase chain reaction and the molecular genetic analysis of tissue biopsies. In Diagnostic Molecular Pathology, a Practical Approach, Vol. II, Herrington CS and McGee JO'D (eds.) pp. 85-111. Oxford University Press: Oxford, New York, Tokyo.
29. SOMERS KD, MERRICK MA, LOPEZ ME, INCOGNITO LS, SCHECHTER GL AND CASEY G. (1992). Frequent p53 mutations in head and neck cancer. Cancer Res., 52, 5997-6000.
30. THORLACIUS S, BÖRRESEN AL AND EYFJÖRD JE. (1993). Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor. Cancer Res., 53, 1637-1641.
31. VOJTÉŠÉK B, BÁRTEK J. MIDGLEY CA AND LANE DP. (1992). An immunochemical analysis of the human nuclear phosphoprotein p53. J. Immunol. Methods, 151, 237-244.
32. WRIGHT DK AND MANOS MM. (1990). Sample preparation from paraffin-embedded tissues. In PCR Protocols, a Guide to Methods and Applications, Innis MA, Gelfand DH, Sninsky JJ and White TJ (eds.) pp. 153-158. Academic Press: San Diego, California.
33. WU JK, YE Z AND DARRAS BT. (1993). Sensitivity of single-strand conformation polymorphism (SSCP) analysis in detecting p53 point mutations in tumors with mixed cell populations. Am. J. Hum. Genet., 52 1273-1275.
34. WU X, BAYLE H, OLSON D AND LEVINE AJ. (1993). The p53-mdm-2 autoregulatory feedback loop. Genes Dev., 7, 1126-1132.
35. ZARIWALA M, SCHMID S, PFALTZ M, OHGAKI H, KLEIHUES P AND SCHÄFER R. (1994). p53 gene mutations in oropharyngeal carcinomas: a comparison of solitary and multiple primary tumours and lymph-node metastases. Int. J. Cancer, 56, 807-811.
36. ZIEGLER A, JONASON AS, LEFFELL DJ, SIMON JA, SHARMA HW, KIMMELMAN J, REMINGTON L, JACKS T AND BRASH DE. (1994). Sunburn and p53 in the onset of skin cancer. Nature, 372, 773-776.